Maastricht Radiation Oncology clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 106 studies whose lead sponsor is Maastricht Radiation Oncology. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Maastricht Radiation Oncology studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Maastricht Radiation Oncology leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 106. Browse all 106 →
- Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT04648462
- Outcome Prediction in Head&Neck Cancer Patients After RadiotherapyRecruitingNCT01985984
- DETECT: Target Volume for Rectal Endoluminal Radiation BoostingRecruitingNCT04927897
- Registry Maastro ApplicatorRecruitingNCT07501845
- Developing Breast (Cancer) OrganoidsRecruitingNCT05317221
- Lab Research Using Mini-tumors to Study Prostate Cancer TreatmentsRecruitingNCT07004582
- A Living Tissue Bank of Patient-Derived Organoids From Glioma TumorsRecruitingNCT04865315
- Biobank Carcinoma: Storing Blood and Protein of Patients With CancerRecruitingNCT01084785
- In Vivo Treatment Verification of BrachytherapyRecruitingNCT06240559
- Personal Health Train for Radiation Oncology in India and The NetherlandsCompletedNCT04655469
- ARtificial Intelligence for Gross Tumour vOlume SegmentationActive, not recruitingNCT05775068
- Patient-derived Glioma Stem Cell OrganoidsActive, not recruitingNCT04868396
- Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AICompletedNCT05565313
- Lung Cancer Organoids and Patient Derived Tumor XenograftsActive, not recruitingNCT05092009
- PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRIActive, not recruitingNCT04638478
- Effect of stRess and exeRcize on the Outcome After Chemo-RadiationCompletedNCT05431348
- Vestibular Schwannoma OrganoidsCompletedNCT05786144
- Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II TrialActive, not recruitingNCT04432142
- The Effect of 360° Virtual Reality Movies on Fear and AnxietyCompletedNCT06199050Not applicable
- The Head and Neck Tumor BiobankCompletedNCT01644786
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruitingNCT06087718Not applicable
- Precision Radiation Treatment for Epilepsy (PRECISION)Active, not recruitingNCT05182437Not applicable
- Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment StrategyActive, not recruitingNCT02284308
- Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung CancerWithdrawnNCT06024941Phase 2
- The Addition of Chloroquine to Chemoradiation for Glioblastoma,WithdrawnNCT02432417Phase 2
- Spatial Location of Breast Cancer Local Recurrence After MastectomyActive, not recruitingNCT06130111
- Standard of Care Lifestyle Support for Stage III NSCLC PatientsWithdrawnNCT05287971
- Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung CancerCompletedNCT03406468Phase 2
- Prospective Primary Human Lungcancer Organoids to Predict Treatment ResponseCompletedNCT04859166
- Radiotherapy After Primary Chemotherapy for BreastcancerCompletedNCT01279304
- Immune Profiling After HDR in Local Relapsed Prostate CancerCompletedNCT04247217
- Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour GrowthCompletedNCT03305380
- Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.CompletedNCT03292341Not applicable
- Evaluation of a Web-based Decision Aid Tool for Prostate Cancer PatientsCompletedNCT03278197Not applicable
- Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain MetastasesTerminatedNCT02353000Not applicable
- Prone Breast Irradiation for Pendulous BreastsCompletedNCT00181363Not applicable
- The Addition of Chloroquine to Chemoradiation for GlioblastomaCompletedNCT02378532Phase 1
- Exploratory Study on Therapy for Breath Hold in RadiotherapyCompletedNCT03729661Not applicable
- Echocardiography for RILI PredictionTerminatedNCT02501707
- BioXmark, Rectal Feasibility TrialCompletedNCT03265418Not applicable
- Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.CompletedNCT02029222
- Detection of Circulating Biomarkers of Immunogenic Cell DeathCompletedNCT02921854Not applicable
- Predicting Outcome in Cervix Carcinoma: a Prospective StudyCompletedNCT01825005
- SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or ChemoradiationCompletedNCT01855191
- Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum CancerCompletedNCT00409994Phase 1/2
- Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer PatientsCompletedNCT03385031
- 20K Distributed Learning ChallengeCompletedNCT03564457
- Tumor Hypoxia With HX4 PET in Several DiseasesTerminatedNCT02584400Phase 2
- PET CT With HX4 in Cervix CancerTerminatedNCT02233387Phase 2
- Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) PatientsTerminatedNCT00969306Phase 1